Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 12, 2023

SELL
$60.95 - $75.51 $25.5 Million - $31.6 Million
-419,099 Closed
0 $0
Q1 2023

Apr 13, 2023

SELL
$70.23 - $86.01 $3.7 Million - $4.53 Million
-52,677 Reduced 11.17%
419,099 $30.3 Million
Q4 2022

Jan 18, 2023

BUY
$67.18 - $84.11 $1.98 Million - $2.48 Million
29,520 Added 6.67%
471,776 $0
Q3 2022

Oct 20, 2022

SELL
$66.18 - $82.86 $3.74 Million - $4.68 Million
-56,474 Reduced 11.32%
442,256 $29.5 Million
Q2 2022

Jul 12, 2022

SELL
$66.18 - $83.18 $1.08 Million - $1.36 Million
-16,390 Reduced 3.18%
498,730 $37.9 Million
Q1 2022

Apr 25, 2022

BUY
$66.02 - $79.71 $2.69 Million - $3.24 Million
40,710 Added 8.58%
515,120 $40.9 Million
Q4 2021

Jan 26, 2022

BUY
$63.34 - $74.11 $3.62 Million - $4.24 Million
57,224 Added 13.72%
474,410 $34.8 Million
Q3 2021

Oct 26, 2021

BUY
$68.67 - $84.02 $2.41 Million - $2.95 Million
35,076 Added 9.18%
417,186 $28.7 Million
Q2 2021

Jul 19, 2021

SELL
$79.87 - $87.53 $146,561 - $160,617
-1,835 Reduced 0.48%
382,110 $32.1 Million
Q1 2021

Apr 16, 2021

BUY
$76.02 - $100.5 $8.51 Million - $11.3 Million
111,991 Added 41.18%
383,945 $31.2 Million
Q4 2020

Feb 03, 2021

SELL
$80.74 - $97.7 $13,079 - $15,827
-162 Reduced 0.06%
271,954 $23.7 Million
Q3 2020

Oct 15, 2020

BUY
$85.07 - $109.69 $6.14 Million - $7.92 Million
72,229 Added 36.13%
272,116 $24.4 Million
Q2 2020

Jul 27, 2020

SELL
$74.18 - $108.93 $14 Million - $20.6 Million
-188,664 Reduced 48.56%
199,887 $20.8 Million
Q1 2020

Apr 17, 2020

BUY
$63.18 - $85.97 $646,078 - $879,129
10,226 Added 2.7%
388,551 $28.5 Million
Q4 2019

Jan 08, 2020

BUY
$73.04 - $95.72 $578,330 - $757,910
7,918 Added 2.14%
378,325 $33 Million
Q3 2019

Oct 10, 2019

BUY
$72.82 - $86.52 $276,643 - $328,689
3,799 Added 1.04%
370,407 $27.5 Million
Q2 2019

Jul 11, 2019

BUY
$73.52 - $88.7 $137,923 - $166,401
1,876 Added 0.51%
366,608 $31.1 Million
Q1 2019

Apr 17, 2019

BUY
$63.56 - $88.17 $2.01 Million - $2.78 Million
31,566 Added 9.47%
364,732 $31.4 Million
Q4 2018

Feb 04, 2019

BUY
$58.5 - $69.94 $990,814 - $1.18 Million
16,937 Added 5.36%
333,166 $21.2 Million
Q3 2018

Nov 09, 2018

BUY
$61.75 - $74.23 $5.15 Million - $6.19 Million
83,446 Added 35.85%
316,229 $21.8 Million
Q2 2018

Aug 10, 2018

BUY
$60.85 - $83.98 $14.2 Million - $19.5 Million
232,783 New
232,783 $15.6 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.